Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer.
Cancer Cell Int
; 22(1): 336, 2022 Nov 04.
Article
de En
| MEDLINE
| ID: mdl-36333801
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Prognostic_studies
Langue:
En
Journal:
Cancer Cell Int
Année:
2022
Type de document:
Article
Pays d'affiliation:
Italie
Pays de publication:
Royaume-Uni